According to Kringle Pharma latest financial reports the cash on hand of 4884 is $14.78M, an decrease of -22.49% to 2022. At the end of 2022 company had $19.07M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $14.78M | -22.49% |
2022 | $19.07M | 28.95% |
2021 | $14.79M | 1.66% |
2020 | $14.55M | 1162.97% |
2019 | $1.15M | -67.05% |
2018 | $3.50M | - |